MetaCap

Haleon plc ADR (HLN)

NYSE: HLNConsumer DiscretionaryPackage Goods/CosmeticsUSD

9.07+0.02 (+0.22%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HLN stock chart

Technical analysis

Key statistics

All statistics
Market cap
$39.76B
Dividend yield
0.80% ($0.073)
Ex-dividend date
Aug 14, 2026
52-week range
8.38 – 11.28
Day range
9.07 – 9.17
Volume / Avg
17.96M / 19.19M
Beta
—

52-week range

$8.38$11.28

HLN stock today

Shares of Haleon (HLN) finished higher on Nov 20 at $9.07, a gain of 0.22% or $0.02 per share, versus the S&P 500's 3.70% decline. At this level, HLN sits in the middle of its 52-week range of $8.38 to $11.28: 19.6% below the high, set on Feb 18, 2026 and 8.2% above the low. HLN is down 10.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 8.1%.

At 18.5x trailing earnings, Haleon trades below the peer-group median of 38.4x. Its forward P/E of 15.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Haleon pays an annual dividend of $0.073 per share, a 0.80% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Haleon

Company profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.

Industry
Package Goods/Cosmetics
CEO
Mr. Brian James McNamara
Headquarters
Weybridge
Employees
24,535
IPO year
2022
Website
haleon.com

Analyst forecast

Forecast

Consensus (5 analysts)

buy

Avg. price target

$10.40+14.66%

  • Strong buy 3
  • Buy 0
  • Hold 2
  • Sell 0
  • Strong sell 0

Target range

Low $9.79High $11.40

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Dividends

Dividend history
Annual dividend
$0.073
Last payment
$0.064
Ex-dividend date
Aug 14, 2026

HLN news

All HLN news

Haleon peers

Consumer Discretionary sector
HLN peer companies
CompanyPrice% ChgMarket capCompare
ELEstee Lauder Companies Inc. (The)99.46-2.27%$36.04Bvs HLN
CHDChurch & Dwight Company Inc.110.84+1.06%$26.16Bvs HLN
ELFe.l.f. Beauty Inc.103.47-5.01%$6.12Bvs HLN
IPARInterparfums Inc.137.42+3.37%$4.40Bvs HLN
COTYCoty Inc. Class A3.95-2.47%$3.48Bvs HLN
SCLStepan Company63.48-2.34%$1.44Bvs HLN
EPCEdgewell Personal Care Company28.47+3.34%$1.31Bvs HLN
CLColgate-Palmolive Company98.71+1.89%$78.47Bvs HLN

Indexes, lists and sector

Haleon stock FAQ

What is Haleon's stock price today?

HLN last traded at $9.07 as of Nov 20, 4:00 PM EST, up 0.22% on the day. Prices are delayed at least 15 minutes.

Does Haleon pay a dividend?

Yes. Haleon pays $0.073 per share annually, a 0.80% yield. The most recent dividend of $0.064 had an ex-dividend date of Aug 14, 2026.

What is HLN's P/E ratio?

HLN trades at a trailing P/E ratio of 18.51 and a forward P/E of 15.01, compared with a median of 38.4 for its closest peers.

Who is Haleon's CEO?

Mr. Brian James McNamara is the chief executive officer of Haleon plc ADR, which has about 24,535 employees.

What is the HLN 52-week high?

The 52-week high for HLN is $11.28 and the 52-week low is $8.38. The stock is currently 19.6% below its high.

Compare HLN